Arkolith/Insider Trading/RLAY/Form 4

Catinazzo Thomas

Chief Financial OfficerRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Mar 31, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 27, 2025Sell(S)5K$2.84$13K375K
Mar 27, 2025Sell(S)298$2.84$846379K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-047725) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML